Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)

PA McCullough, PE Alexander… - Reviews in …, 2020 - scholarlycommons.henryford.com
The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness,
hospitalizations, and death. The complex and multifaceted pathophysiology of life …

[HTML][HTML] Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection

BC Procter, C Ross, V Pickard, E Smith… - Reviews in …, 2020 - imrpress.com
There is an emergency need for early ambulatory treatment of Coronavirus Disease 2019
(COVID-19) in acutely ill patients in an attempt to reduce disease progression and the risks …

Clinical trials on the pharmacological treatment of long COVID: A systematic review

YJ Chee, BE Fan, BE Young, R Dalan… - Journal of Medical …, 2023 - Wiley Online Library
The postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
infection (PASC), also known as post‐acute coronavirus disease 19 (COVID‐19) or the long …

[HTML][HTML] Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines

X Xu, YK Ong, DY Wang - Military Medical Research, 2020 - Springer
Abstract The coronavirus disease (COVID-19) pandemic has led to a global struggle to cope
with the sheer numbers of infected persons, many of whom require intensive care support or …

Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents

PE Alexander, R Armstrong, G Fareed, J Lotus… - Medical hypotheses, 2021 - Elsevier
The outbreak of COVID-19 from severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has spread all over the world with tremendous morbidity and mortality in the elderly …

Therapy for early COVID-19: a critical need

PS Kim, SW Read, AS Fauci - Jama, 2020 - jamanetwork.com
While coronavirus disease 2019 (COVID-19) is predominantly self-limited, up to 20% of
symptomatic individuals will progress to severe or critical disease with clinical …

Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research

F Ceban, A Leber, MY Jawad, M Yu, LMW Lui… - Infectious …, 2022 - Taylor & Francis
Background A considerable proportion of individuals report persistent, debilitating and
disparate symptoms despite resolution of acute COVID-19 infection (ie long COVID) …

[HTML][HTML] Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) infection

PA McCullough, RJ Kelly, G Ruocco, E Lerma… - The American journal of …, 2021 - Elsevier
Approximately 9 months of the severe acute respiratory syndrome coronavius-2 (SARS-CoV-
2 [COVID-19]) spreading across the globe has led to widespread COVID-19 acute …

Early outpatient treatment of symptomatic, high-risk COVID-19 patients that should be ramped up immediately as key to the pandemic crisis

HA Risch - American journal of epidemiology, 2020 - academic.oup.com
More than 1.6 million Americans have been infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), and more than 10 times that number carry antibodies to it …

[HTML][HTML] Preliminary guidelines for the clinical evaluation and management of long COVID

Y Kim, SE Kim, T Kim, KW Yun, SH Lee… - Infection & …, 2022 - ncbi.nlm.nih.gov
Long-lasting coronavirus disease 2019 (COVID-19) symptoms beyond 12 weeks, the so-
called 'long COVID'have been increasingly reported worldwide. Long COVID can be …